Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Robert O'Connor, Martin Clynes, Paul Dowling, Norma O'Donovan & Lorraine O'Driscoll. (2007) Drug resistance in cancer – searching for mechanisms, markers and therapeutic agents. Expert Opinion on Drug Metabolism & Toxicology 3:6, pages 805-817.
Read now
Read now
Takayuki Saitoh$suffix/text()$suffix/text(), Takafumi Matsushima, Hirono Iriuchishima, Arito Yamane, Hiroyuki Irisawa, Hiroshi Handa, Norifumi Tsukamoto, Masamitsu Karasawa, Yoshihisa Nojima & Hirokazu Murakami. (2006) Presentation of extramedullary Philadelphia chromosome-positive biphenotypic acute leukemia as testicular mass: Response to imatinib-combined chemotherapy. Leukemia & Lymphoma 47:12, pages 2667-2669.
Read now
Read now
Roberto R Rosato & Steven Grant. (2005) Histone deacetylase inhibitors: insights into mechanisms of lethality. Expert Opinion on Therapeutic Targets 9:4, pages 809-824.
Read now
Read now
A ML Coluccia, R H Gunby, C J Tartari, L Scapozza, C Gambacorti-Passerini & Lorena Passoni. (2005) Anaplastic lymphoma kinase and its signalling molecules as novel targets in lymphoma therapy. Expert Opinion on Therapeutic Targets 9:3, pages 515-532.
Read now
Read now
Faris QB Alenzi, Richard KH Wyse & Waleed G Altamimi. (2004) Apoptosis as a tool for therapeutic agents in haematological diseases. Expert Opinion on Biological Therapy 4:3, pages 407-420.
Read now
Read now
Articles from other publishers (37)
Fuhua Yang, Ping Wang, Jia Wan, Xiaoqing Jia, An Zhou, Yuan Zhang, Jiani Song, Qiang Gong, Wei-Dong Li & Jieping Chen. (2023) Clonal evolution analyses of a chronic myeloid leukemia patient with hematopoietic stem cell transplantation based on deep sequencing. Holistic Integrative Oncology 2:1.
Crossref
Crossref
Mayura Kale, Gajanan Sonwane & Yogesh Choudhari. (2020) Searching for Potential Novel BCR-ABL Tyrosine Kinase Inhibitors Through G-QSAR and Docking Studies of Some Novel 2-Phenazinamine Derivatives. Current Computer-Aided Drug Design 16:5, pages 501-510.
Crossref
Crossref
Garrett W. Rhyasen, Lyndsey Bolanos, Jing Fang, Andres Jerez, Mark Wunderlich, Carmela Rigolino, Lesley Mathews, Marc Ferrer, Noel Southall, Rajarshi Guha, Jonathan Keller, Craig Thomas, Levi J. Beverly, Agostino Cortelezzi, Esther N. Oliva, Maria Cuzzola, Jaroslaw P. Maciejewski, James C. Mulloy & Daniel T. Starczynowski. (2013) Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome. Cancer Cell 24:1, pages 90-104.
Crossref
Crossref
Nicole St-Denis & Anne-Claude Gingras. 2012. Protein Phosphorylation in Health and Disease. Protein Phosphorylation in Health and Disease
3
32
.
Leslie W. Tari. 2012. Structure-Based Drug Discovery. Structure-Based Drug Discovery
1
27
.
Yong Xu, Fang Fang, Yulan Sun, Daret K. St. Clair & William H. St. Clair. (2010) RelB-Dependent Differential Radiosensitization Effect of STI571 on Prostate Cancer Cells. Molecular Cancer Therapeutics 9:4, pages 803-812.
Crossref
Crossref
Massimo Breccia & Giuliana Alimena. (2010) Nilotinib: A second-generation tyrosine kinase inhibitor for chronic myeloid leukemia. Leukemia Research 34:2, pages 129-134.
Crossref
Crossref
Tim Beissert, Alena Hundertmark, Velina Kaburova, Lorena Travaglini, Afsar A. Mian, Clara Nervi & Martin Ruthardt. (2008) Targeting of the N‐terminal coiled coil oligomerization interface by a helix‐2 peptide inhibits unmutated and imatinib‐resistant BCR/ABL. International Journal of Cancer 122:12, pages 2744-2752.
Crossref
Crossref
Satoru Matsuda, Yasukatu Ichigotani, Naoko Okumura, Hitomi Yoshida, Yuka Kajiya, Yasuko Kitagishi & Naoki Shirafuji. (2008) NESH protein expression switches to the adverse effect of imatinib mesylate. Molecular Oncology 2:1, pages 16-19.
Crossref
Crossref
Benjamin E Turk. (2008) Understanding and exploiting substrate recognition by protein kinases. Current Opinion in Chemical Biology 12:1, pages 4-10.
Crossref
Crossref
Elaine S. Jaffe. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
2131
2137
.
Roberto R. Rosato & Steven Grant. 2008. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
115
131
.
Scott N. Boyle & Anthony J. Koleske. (2007) Dissecting kinase signaling pathways. Drug Discovery Today 12:17-18, pages 717-724.
Crossref
Crossref
Simona Margutti & Stefan A. Laufer. (2007) Are MAP Kinases Drug Targets? Yes, but Difficult Ones. ChemMedChem 2:8, pages 1116-1140.
Crossref
Crossref
Sreenath V. Sharma, Patrycja Gajowniczek, Inna P. Way, Diana Y. Lee, Jane Jiang, Yuki Yuza, Marie Classon, Daniel A. Haber & Jeffrey Settleman. (2006) A common signaling cascade may underlie “addiction” to the Src, BCR-ABL, and EGF receptor oncogenes. Cancer Cell 10:5, pages 425-435.
Crossref
Crossref
Kohzoh Imai & Akinori Takaoka. (2006) Comparing antibody and small-molecule therapies for cancer. Nature Reviews Cancer 6:9, pages 714-727.
Crossref
Crossref
Jessica Wang-Rodriguez, Jay Patrick Lopez, Xabier Altuna, Theresa S. Chu, Robert A. Weisman & Weg M. Ongkeko. (2006) STI-571 (Gleevec) Potentiates the Effect of Cisplatin in Inhibiting the Proliferation of Head and Neck Squamous Cell Carcinoma In Vitro. The Laryngoscope 116:8, pages 1409-1416.
Crossref
Crossref
Aaron A Berlin, Cory M Hogaboam & Nicholas W Lukacs. (2006) Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma. Laboratory Investigation 86:6, pages 557-565.
Crossref
Crossref
Mariah C. Ruth, William M. Old, Michelle A. Emrick, Karen Meyer-Arendt, Lauren D. Aveline-Wolf, Kevin G. Pierce, Alex M. Mendoza, Joel R. Sevinsky, Micah Hamady, Robin D. Knight, Katheryn A. Resing & Natalie G. Ahn. (2006) Analysis of Membrane Proteins from Human Chronic Myelogenous Leukemia Cells: Comparison of Extraction Methods for Multidimensional LC−MS/MS. Journal of Proteome Research 5:3, pages 709-719.
Crossref
Crossref
Dennis Slater, Karyn Ronski, Judy Delach, Peter Benn & Min Fang. (2005) Importance of molecular confirmation in the diagnosis of myeloproliferative disorders. Community Oncology 2:5, pages 418-422.
Crossref
Crossref
Silke Appel, Anette Rupf, Markus M. Weck, Oliver Schoor, Tim H. Brümmendorf, Toni Weinschenk, Frank Grünebach & Peter Brossart. (2005) Effects of Imatinib on Monocyte-Derived Dendritic Cells Are Mediated by Inhibition of Nuclear Factor-κB and Akt Signaling Pathways. Clinical Cancer Research 11:5, pages 1928-1940.
Crossref
Crossref
Hermann Lage. (2005) Potential applications of RNA interference technology in the treatment of cancer. Future Oncology 1:1, pages 103-113.
Crossref
Crossref
Aaron A. Berlin & Nicholas W. Lukacs. (2005) Treatment of Cockroach Allergen Asthma Model with Imatinib Attenuates Airway Responses. American Journal of Respiratory and Critical Care Medicine 171:1, pages 35-39.
Crossref
Crossref
Alexander A. Shtil*Janeen Azare†. 2005.
1
29
.
Zafar Iqbal, Rubina T Siddiqui, Javed A Qureshi & Ahmad M Khalid. (2004) Case study of primary imatinib resistance and correlation of BCR-ABL multiple mutations in chronic myeloid leukemia. Therapy 1:2, pages 249-254.
Crossref
Crossref
Kien Vuu, Sunil D. Pandit & King C.P. Li. (2004) A primer on molecular biology for imagers. Academic Radiology 11, pages 54-65.
Crossref
Crossref
B?la Papp, Jean-Philippe Brouland, Pascal G?l?bart, T?nde Kov?cs & Christine Chomienne. (2004) Endoplasmic reticulum calcium transport ATPase expression during differentiation of colon cancer and leukaemia cells. Biochemical and Biophysical Research Communications 322:4, pages 1223-1236.
Crossref
Crossref
Katherine R Calvo, Alexandra Traverse-Glehen, Stefania Pittaluga & Elaine S Jaffe. (2004) Molecular Profiling Provides Evidence of Primary Mediastinal Large B-Cell Lymphoma as a Distinct Entity Related to Classic Hodgkin Lymphoma. Advances in Anatomic Pathology 11:5, pages 227-238.
Crossref
Crossref
Geraldo Barroso Cavalcanti, Flavia da Cunha Vasconcelos, Giselle Pinto de Faria, Marcos Ant�nio Maur�cio Scheiner, Jane de Almeida Dobbin, Claudete Esteves Klumb & Raquel C. Maia. (2004) Coexpression of p53 protein and MDR functional phenotype in leukemias: The predominant association in chronic myeloid leukemia. Cytometry 61B:1, pages 1-8.
Crossref
Crossref
Virginia E. Kwitkowski & Janine R. Daub. (2004) Clinical applications of genetics in sporadic cancers. Seminars in Oncology Nursing 20:3, pages 155-163.
Crossref
Crossref
Steven Grant & Paul Dent. (2004) Gene profiling and the cyclin-dependent kinase inhibitor flavopiridol: What's in a name?. Molecular Cancer Therapeutics 3:7, pages 873-875.
Crossref
Crossref
Clifford D. Mol, Douglas R. Dougan, Thomas R. Schneider, Robert J. Skene, Michelle L. Kraus, Daniel N. Scheibe, Gyorgy P. Snell, Hua Zou, Bi-Ching Sang & Keith P. Wilson. (2004) Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase. Journal of Biological Chemistry 279:30, pages 31655-31663.
Crossref
Crossref
Kien Vuu, Sunil D Pandit & King C.P Li. (2004) A primer on molecular biology for imagers. Academic Radiology 11:7, pages 817-828.
Crossref
Crossref
Hye Jin Lee, Sol Kim, Jerry Pelletier & Jungho Kim. (2004)
Stimulation of hTAF
II
68 (NTD)-mediated transactivation by v-Src
. FEBS Letters 564:1-2, pages 188-198.
Crossref
Crossref
Joshua L. Paterson, Zhihua Li, Xiao-Yan Wen, Esther Masih-Khan, Hong Chang, Jonathan B. Pollett, Suzanne Trudel & A. Keith Stewart. (2004) Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma. British Journal of Haematology 124:5, pages 595-603.
Crossref
Crossref
Zafar Iqbal, Rubina T. Siddiqui & Javed A. Qureshi. (2004) Two different point mutations in ABL gene ATP-binding domain conferring primary imatinib resistance in a chronic myeloid leukemia (CML) patient: A case report. Biological Procedures Online 6:1.
Crossref
Crossref
Samuel E. Hernández, Maithreyi Krishnaswami, Ann L. Miller & Anthony J. Koleske. (2004) How do Abl family kinases regulate cell shape and movement?. Trends in Cell Biology 14:1, pages 36-44.
Crossref
Crossref